Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions
Clin. transl. oncol. (Print)
; 19(3): 341-356, mar. 2017. tab, graf
Article
en En
| IBECS
| ID: ibc-160190
Biblioteca responsable:
ES1.1
Ubicación: BNCS
ABSTRACT
Purpose. The Spanish Society of Medical Oncology (SEOM) has conducted a study on the access to oncologic drugs across the 17 Spanish Regions with the aim of identifying potential heterogeneities and making proposals for eliminating the barriers identified at the different levels. Methods. An Expert Panel made up of medical oncologists designed a survey on certain indications approved for 11 drugs in the approach of breast cancer, melanoma, lung cancer, prostate cancer and support treatment. This survey was sent to 144 National Health System (NHS) hospitals. Results. 77 hospitals answered the survey. The information modules analysed were: scope of the Commission that establishes binding decisions related to drug access; conditions, stages and periods of drug application, approval and administration processes; barriers to accessing drugs. Conclusions. The study shows variability in drug access. The SEOM makes proposals addressed to reducing the differences identified and homogenizing drug access conditions (AU)
RESUMEN
No disponible
Texto completo:
1
Colección:
06-national
/
ES
Base de datos:
IBECS
Asunto principal:
Sociedades Médicas
/
Sistemas de Salud
/
Servicio de Oncología en Hospital
/
Antineoplásicos
Tipo de estudio:
Prognostic_studies
Aspecto:
Equity_inequality
/
Patient_preference
Límite:
Female
/
Humans
/
Male
Idioma:
En
Revista:
Clin. transl. oncol. (Print)
Año:
2017
Tipo del documento:
Article